Funded under the National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3, Theme 10.
A guideline of actual risks and benefits for the food chain will be realised to promote an independent point of view. Safety of bacteria derived from genome editing (GE) by using intragenesis and synthetic biology will be assessed using model organisms. The RA will be conducted considering deliberate release for food production or for fermentations in confined environments. WGS approaches for RA of GE-strains will be applied. Lab-scale models to study the fate of GE- bacteria and their DNA will be developed following recent EFSA indications.
Systematic review on GMO and NBT practical case studies (M36)
Models for assessing the fate of GE bacteria in food (M36)
EU legislation on GMOs and NBTs aims to ensure a high level of protection of human, animal and environmental health and regulates the environmental release of GMOs or their application in the food chain. On the other hand, genetic engineering aims to improve productivity or reduce damage to food. GM-plants have shown the prospect of being able to fill the massive demand for food. GM-microbes have demonstrated their potential to contribute to plant growth by exerting greater bioremediation efficiency on polluted soils or by providing a greener and more economical strategy than those actually adopted. The direct application of GM-microorganisms is, instead, directed to improve food production through the contribution of enzymes, vitamins, or new food components.
The resulting representation clearly led to the EU and EFSA request for a detailed risk assessment (RA) before validating the large-scale application of a novel GMO.
A detailed workflow will follow:
The evidence obtained from the meticulous article collection will provide a critical overview and assessment of the risks and benefits deriving from the application GMOs and NBTs in the agri-food chain.